Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) FCF Margin % : -252.92% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ginkgo Bioworks Holdings's Free Cash Flow for the three months ended in Mar. 2024 was $-95.97 Mil. Ginkgo Bioworks Holdings's Revenue for the three months ended in Mar. 2024 was $37.94 Mil. Therefore, Ginkgo Bioworks Holdings's FCF Margin % for the quarter that ended in Mar. 2024 was -252.92%.

As of today, Ginkgo Bioworks Holdings's current FCF Yield % is -22.04%.

The historical rank and industry rank for Ginkgo Bioworks Holdings's FCF Margin % or its related term are showing as below:

During the past 5 years, the highest FCF Margin % of Ginkgo Bioworks Holdings was -63.74%. The lowest was -252.62%. And the median was -123.43%.

DNA.WS's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -144.01
* Ranked among companies with meaningful FCF Margin % only.

Ginkgo Bioworks Holdings FCF Margin % Historical Data

The historical data trend for Ginkgo Bioworks Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings FCF Margin % Chart

Ginkgo Bioworks Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-123.43

-252.62

-98.89

-63.74

-133.74

Ginkgo Bioworks Holdings Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial											-136.34	-108.07	-140.60	-176.31	-252.92

Competitive Comparison of Ginkgo Bioworks Holdings's FCF Margin %

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ginkgo Bioworks Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's FCF Margin % falls into.

Ginkgo Bioworks Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ginkgo Bioworks Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-336.301	/	251.455
	=	-133.74 %

Ginkgo Bioworks Holdings's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-95.969	/	37.944
	=	-252.92 %

Ginkgo Bioworks Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DNA:USA DNA:Mexico

Address

27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210

Website

https://www.ginkgobioworks.com

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.